BridgeBio Pharma, Inc. beat EPS estimates 0% of the time across 1 reported quarters (0 beats, 1 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-0.64 | — | — | Miss |
| Q12026 FY2026 | $-0.70 | $-0.84 | -20.0% | Miss |
| 2026-02-19 | $-0.74 | — | — | Miss |
Back to BBIO overview · BBIO holders · BBIO KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.